235 related articles for article (PubMed ID: 23399735)
21. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.
Fasseu M; Tréton X; Guichard C; Pedruzzi E; Cazals-Hatem D; Richard C; Aparicio T; Daniel F; Soulé JC; Moreau R; Bouhnik Y; Laburthe M; Groyer A; Ogier-Denis E
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957151
[TBL] [Abstract][Full Text] [Related]
22. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease.
Konstantinidis AΟ; Pardali D; Adamama-Moraitou KK; Gazouli M; Dovas CI; Legaki E; Brellou GD; Savvas I; Jergens AE; Rallis TS; Allenspach K
BMC Vet Res; 2020 Feb; 16(1):69. PubMed ID: 32087719
[TBL] [Abstract][Full Text] [Related]
23. Expression of Wnt pathway components frizzled and disheveled in colon cancer arising in patients with inflammatory bowel disease.
You XJ; Bryant PJ; Jurnak F; Holcombe RF
Oncol Rep; 2007 Sep; 18(3):691-4. PubMed ID: 17671721
[TBL] [Abstract][Full Text] [Related]
24. miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis.
Benderska N; Dittrich AL; Knaup S; Rau TT; Neufert C; Wach S; Fahlbusch FB; Rauh M; Wirtz RM; Agaimy A; Srinivasan S; Mahadevan V; Rümmele P; Rapti E; Gazouli M; Hartmann A; Schneider-Stock R
Inflamm Bowel Dis; 2015 Sep; 21(9):2039-51. PubMed ID: 26083618
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.
Khare V; Dammann K; Asboth M; Krnjic A; Jambrich M; Gasche C
Inflamm Bowel Dis; 2015 Feb; 21(2):287-96. PubMed ID: 25569743
[TBL] [Abstract][Full Text] [Related]
26. Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease.
Sohn JJ; Schetter AJ; Yfantis HG; Ridnour LA; Horikawa I; Khan MA; Robles AI; Hussain SP; Goto A; Bowman ED; Hofseth LJ; Bartkova J; Bartek J; Wogan GN; Wink DA; Harris CC
PLoS One; 2012; 7(9):e44156. PubMed ID: 22970173
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
29. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
[TBL] [Abstract][Full Text] [Related]
30. MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways.
Gong B; Liu WW; Nie WJ; Li DF; Xie ZJ; Liu C; Liu YH; Mei P; Li ZJ
World J Gastroenterol; 2015 Feb; 21(5):1488-97. PubMed ID: 25663768
[TBL] [Abstract][Full Text] [Related]
31. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
32. Tumor suppressor functions of miR-133a in colorectal cancer.
Dong Y; Zhao J; Wu CW; Zhang L; Liu X; Kang W; Leung WW; Zhang N; Chan FK; Sung JJ; Ng SS; Yu J
Mol Cancer Res; 2013 Sep; 11(9):1051-60. PubMed ID: 23723074
[TBL] [Abstract][Full Text] [Related]
33. Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon.
Zahm AM; Hand NJ; Tsoucas DM; Le Guen CL; Baldassano RN; Friedman JR
J Crohns Colitis; 2014 Sep; 8(9):1108-17. PubMed ID: 24613022
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease.
Maharshak N; Shenhar-Tsarfaty S; Aroyo N; Orpaz N; Guberman I; Canaani J; Halpern Z; Dotan I; Berliner S; Soreq H
Inflamm Bowel Dis; 2013 Jun; 19(7):1346-53. PubMed ID: 23598815
[TBL] [Abstract][Full Text] [Related]
35. [Expression of microRNA-155 in inflammatory bowel disease and its clinical significance].
Ye YL; Pang Z; Gu W; Zheng JJ
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3716-3719. PubMed ID: 29325325
[No Abstract] [Full Text] [Related]
36. Vitamin D deficiency enhances expression of autophagy-regulating miR-142-3p in mouse and "involved" IBD patient intestinal tissues.
McGillis L; Bronte-Tinkew DM; Dang F; Capurro M; Prashar A; Ricciuto A; Greenfield L; Lozano-Ruf A; Siddiqui I; Hsieh A; Church P; Walters T; Roth DE; Griffiths A; Philpott D; Jones NL
Am J Physiol Gastrointest Liver Physiol; 2021 Aug; 321(2):G171-G184. PubMed ID: 34159811
[TBL] [Abstract][Full Text] [Related]
37. Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).
Wei M; Liu B; Gu Q; Su L; Yu Y; Zhu Z
Cell Oncol (Dordr); 2013 Feb; 36(1):79-93. PubMed ID: 23184467
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer.
Ng EK; Tsang WP; Ng SS; Jin HC; Yu J; Li JJ; Röcken C; Ebert MP; Kwok TT; Sung JJ
Br J Cancer; 2009 Aug; 101(4):699-706. PubMed ID: 19638978
[TBL] [Abstract][Full Text] [Related]
39. Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells.
Kurokawa K; Tanahashi T; Iima T; Yamamoto Y; Akaike Y; Nishida K; Masuda K; Kuwano Y; Murakami Y; Fukushima M; Rokutan K
J Gastroenterol; 2012 Aug; 47(8):883-95. PubMed ID: 22382630
[TBL] [Abstract][Full Text] [Related]
40. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.
Yi C; Wang Q; Wang L; Huang Y; Li L; Liu L; Zhou X; Xie G; Kang T; Wang H; Zeng M; Ma J; Zeng Y; Yun JP
Oncogene; 2012 Oct; 31(41):4421-33. PubMed ID: 22249270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
